# Oshen

> Oshen is a VC fund backing Therapeutics and Biotechnology. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 4
- Last investment: Jul 2026
- Lead investor: 50%
- Last updated: Aug 2026
- Website: http://oshenbio.com

Oshen is a VC fund focused on Therapeutics and Biotechnology. Oshen is invest in inventors and visionaries and developing the ideas and products.

## Contacts

5 contacts available for Oshen. Shizune tracks 1 team members at Oshen. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/oshen-61bf?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 1 | 25% |
| Biotechnology | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Didier Cowling | Managing Partner | 3 | https://shizune.co/investors/profile/didier-cowling |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Healome Therapeutics | Healome Therapeutics | $2.7M | Seed | Jul 07, 2026 |  |
| Scarlet Therapeutics | Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform. | $4.4M | Seed | May 07, 2026 |  |
| 4D Medicine | 4D Medicine focuses on providing biomaterials and medical device solutions, particularly in the area of bioresorbable polymers. The company specializes in developing materials for 3D printing for medical applications, such as implants and devices that naturally dissolve in the body. It collaborates with partners to enhance innovation in the designand manufacturing processes for medical devices. Additionally, it offers design services to support commercial partners in advancing product development. | $4.4M | Series A | Jul 25, 2024 |  |
| Topadur Pharma | Topadur Pharma has experienced scientists that combine several years of expertise in R and D Pharma. Their mission is to improve the quality of life of patients by developing high-quality, safe drugs for unmet medical needs. The company focuses on the research and development of innovative dual-mode drugs for the treatment of aging-relateddiseases. | $3.4M | Venture - Series Unknown | Jun 06, 2024 |  |

4 of 4 investments shown.

## Co-investors
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund, 2 deals together
- [Boundary Capital Partners LLP](https://shizune.co/investors/profile/boundary-capital) — VC Fund, 1 deal together
- [Cure EB](https://shizune.co/investors/profile/cure-eb) — VC Fund, 1 deal together
- [Daft Capital](https://shizune.co/investors/profile/daft-capital) — VC Fund, 1 deal together
- [DEBRA Research](https://shizune.co/investors/profile/debra-research) — VC Fund, 1 deal together
- [DSW Ventures](https://shizune.co/investors/profile/dow-schofield-watts-angels) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Oshen invest in?

Oshen invests primarily in Therapeutics and Biotechnology startups, most often at Seed stage. Most of the 4 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Oshen?

Public channels for Oshen include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Oshen?

The team at Oshen includes Didier Cowling (Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co